OSCR · NYSE
Oscar Health (OSCR) Stock Price & Fundamentals
Oscar Health (OSCR) closed at $535.00 on Oct 9, 2026, up 0.18% from the previous close of $534.05.
Share price, past year
1Y +6.13%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $535.00 |
| Sep 30, 2026 | $546.92 |
| Aug 31, 2026 | $535.17 |
| Jul 31, 2026 | $567.18 |
| Jun 30, 2026 | $527.67 |
| May 29, 2026 | $513.27 |
| Apr 30, 2026 | $544.83 |
| Mar 31, 2026 | $590.92 |
| Feb 27, 2026 | $583.89 |
| Jan 30, 2026 | $567.65 |
| Dec 31, 2025 | $552.68 |
| Nov 28, 2025 | $535.23 |
| Oct 31, 2025 | $537.16 |
Key statistics
- Market cap
- —
- P/E (TTM)
- 369.0
- EPS (TTM)
- $1.45
- Revenue (TTM)
- $15.32B
- Net income (TTM)
- $550.74M
- Shares outstanding
- —
- Dividend yield
- —
- 52-week range
- $504.11 – $601.17
Financials
Oscar Health reported revenue of $11.70B for fiscal 2025, up 27.50% from fiscal 2024.
Oscar Health reported a net loss of $443.15M in fiscal 2025.
Fiscal 2025 revenue was the highest in the 7 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $11.70B | +27.5% | −$443.15M | −3.8% | −$1.69 | — |
| FY2024ended Dec 31, 2024 | $9.18B | +56.5% | $25.43M | 0.3% | $0.10 | — |
| FY2023ended Dec 31, 2023 | $5.86B | +47.9% | −$270.73M | −4.6% | −$1.22 | — |
| FY2022ended Dec 31, 2022 | $3.96B | +115.6% | −$606.28M | −15.3% | −$2.85 | — |
| FY2021ended Dec 31, 2021 | $1.84B | +297.3% | −$572.61M | −31.1% | −$3.20 | — |
| FY2020ended Dec 31, 2020 | $462.80M | −5.2% | −$406.83M | −87.9% | −$14.16 | — |
| FY2019ended Dec 31, 2019 | $488.19M | — | −$261.18M | −53.5% | −$9.06 | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $4.88B | $361.81M | $1.10 |
| Q1 FY2026ended Mar 31, 2026 | $4.65B | $679.00M | $2.07 |
| Q4 FY2025ended Dec 31, 2025 | $2.81B | −$352.61M | −$1.19 |
| Q3 FY2025ended Sep 30, 2025 | $2.99B | −$137.45M | −$0.53 |
| Q2 FY2025ended Jun 30, 2025 | $2.86B | −$228.36M | −$0.89 |
| Q1 FY2025ended Mar 31, 2025 | $3.05B | $275.27M | $0.92 |
| Q4 FY2024ended Dec 31, 2024 | $2.39B | −$153.55M | −$0.50 |
| Q3 FY2024ended Sep 30, 2024 | $2.42B | −$54.60M | −$0.22 |
Company profile
- Name
- Oscar Health, Inc.
- Ticker
- OSCR
- Exchange
- NYSE
- Industry (SEC SIC)
- Hospital & Medical Service Plans
- Headquarters
- 75 Varick Street, 5th Floor, New York, NY 10013
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001568651
Recent SEC filings
- Sep 16, 2026
- Aug 7, 2026
- Aug 6, 2026
- Jun 9, 2026
- Jun 8, 2026
- Jun 2, 2026
- May 7, 2026
- May 6, 2026
Frequently asked questions
What is Oscar Health's stock price?
Oscar Health (OSCR) closed at $535.00 on Oct 9, 2026, up 0.18% from the previous close of $534.05.
How much revenue does Oscar Health make?
Oscar Health reported revenue of $11.70B for fiscal 2025, up 27.50% from fiscal 2024.
What is OSCR's P/E ratio?
Oscar Health's price-to-earnings ratio is 369.0, based on trailing twelve-month diluted EPS of $1.45.
Does Oscar Health pay a dividend?
Oscar Health's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Oscar Health, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures